IsomAb Announces Close of £7.5 Million Financing to Accelerate Lead Candidate for Treatment of Peripheral Arterial Disease
Alevin Therapeutics reaches shortlist for Start-up of the Year at the Cambridge Independent Science and Technology Awards 2023
